Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Plasmid-based short hairpin RNA against connective tissue growth factor attenuated monocrotaline-induced pulmonary vascular remodeling in rats

Abstract

Pulmonary hypertension is a life-threatening medical condition, and a growing body of evidence shows that the expression of connective tissue growth factor (CTGF) is significantly associated with its pathogenesis, making it an attractive therapeutic target. Our earlier work revealed that plasmid-based CTGF-specific short hairpin RNA (shRNA) could attenuate pulmonary artery smooth muscle cell (PASMC) proliferation and pulmonary vascular remodeling in rats exposed to cigarette smoke. In this study, we explored the therapeutic role of this shRNA plasmid in the treatment of monocrotaline-induced pulmonary vascular remodeling in rats, and demonstrated that the upregulation of CTGF in PASMCs following a single injection of monocrotaline could be attenuated by administration of the shRNA. Accordingly, this shRNA was found to repress monocrotaline-induced pulmonary vascular remodeling, as evidenced by its ability to reduce the percentage of muscularized vessels and the wall thickness of pulmonary vessels. We concluded that plasmid-based shRNA against CTGF attenuated pulmonary vascular remodeling in monocrotaline-treated rats. CTGF might be a potential target for the treatment of pulmonary vascular remodeling and pulmonary hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Humbert M, Sitbon O, Simonneau G . Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425–1436.

    Article  CAS  Google Scholar 

  2. Pidgeon GP, Tamosiuniene R, Chen G, Leonard I, Belton O, Bradford A et al. Intravascular thrombosis after hypoxia-induced pulmonary hypertension—regulation by cyclooxygenase-2. Circulation 2004; 110: 2701–2707.

    Article  Google Scholar 

  3. Peinado VI, Pizarro S, Barbera JA . Pulmonary vascular involvement in COPD. Chest 2008; 134: 808–814.

    Article  CAS  Google Scholar 

  4. Rabinovitch M . Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2012; 122: 4306–4313.

    Article  CAS  Google Scholar 

  5. Bradham DM, Igarashi A, Potter RL, Grotendorst GR . Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285–1294.

    Article  CAS  Google Scholar 

  6. Babic AM, Chen CC, Lau LF . Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19: 2958–2966.

    Article  CAS  Google Scholar 

  7. Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Fujii T, Luscher TF . Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999; 100: 2108–2112.

    Article  CAS  Google Scholar 

  8. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 1999; 126: 137–145.

    Article  CAS  Google Scholar 

  9. Takigawa M . CTGF/Hcs24 as a multifunctional growth factor for fibroblasts, chondrocytes and vascular endothelial cells. Drug News Perspect 2003; 16: 11–21.

    Article  CAS  Google Scholar 

  10. Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M . Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 2000; 184: 197–206.

    Article  CAS  Google Scholar 

  11. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in ‘fibrosis-resistant’ BALB/c mouse lungs. Am J Respir Cell Mol Biol 2004; 31: 510–516.

    Article  CAS  Google Scholar 

  12. Tian F, Xu YJ, Zhang ZX, Fan XL, Hu J . Role of connective tissue growth factor on pulmonary artery remodeling in rats exposed to smoke. Zhonghua Jie He He Hu Xi Za Zhi 2007; 30: 921–925.

    PubMed  Google Scholar 

  13. Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M . Knockdown of connective tissue growth factor by plasmid-based short hairpin RNA prevented pulmonary vascular remodeling in cigarette smoke-exposed rats. Arch Biochem Biophys 2011; 508: 93–100.

    Article  CAS  Google Scholar 

  14. Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M . CCN2 promotes cigarette smoke-induced proliferation of rat pulmonary artery smooth muscle cells through upregulating cyclin D1 expression. J Cell Biochem 2012; 113: 349–359.

    Article  CAS  Google Scholar 

  15. Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C . The CCN family: a new class of inflammation modulators? Biochimie 2011; 93: 377–388.

    Article  CAS  Google Scholar 

  16. Branchetti E, Poggio P, Sainger R, Shang E, Grau JB, Jackson BM et al. Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res 2013; 100: 316–324.

    Article  CAS  Google Scholar 

  17. Gao DF, Niu XL, Hao GH, Peng N, Wei J, Ning N et al. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells—role of PPAR-gamma in vascular fibrosis. Biochem Pharmacol 2007; 73: 185–197.

    Article  CAS  Google Scholar 

  18. Wang RD, Wright JL, Churg A . Transforming growth factor-beta(1) drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005; 33: 387–393.

    Article  CAS  Google Scholar 

  19. Fan WH, Pech M, Karnovsky MJ . Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 2000; 79: 915–923.

    Article  CAS  Google Scholar 

  20. Li G, Hu Y, Jia P, Fu J, Lu CX, Sun YQ et al. Integrin beta3 pathway mediated connective tissue growth factor-induced proliferation, migration and extracellular matrix deposition of pulmonary arterial smooth muscle cells. Zhonghua Er Ke Za Zhi 2011; 49: 895–900.

    PubMed  Google Scholar 

  21. Kubota S, Hattori T, Shimo T, Nakanishi T, Takigawa M . Novel intracellular effects of human connective tissue growth factor expressed in Cos-7 cells. FEBS Lett 2000; 474: 58–62.

    Article  CAS  Google Scholar 

  22. Chien W, Yin D, Gui D, Mori A, Frank JM, Said J et al. Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. Mol Cancer Res 2006; 4: 591–598.

    Article  CAS  Google Scholar 

  23. Sakai Y, Balam TA, Kuroda S, Tamamura N, Fukunaga T, Takigawa M et al. CTGF and apoptosis in mouse osteocytes induced by tooth movement. J Dent Res 2009; 88: 345–350.

    Article  CAS  Google Scholar 

  24. Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmuller P, Ladage D et al. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation 2013; 128: 512–523.

    Article  CAS  Google Scholar 

  25. Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB . Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 2004; 110: 1499–1506.

    Article  CAS  Google Scholar 

  26. Yuan P, Wu WH, Gao L, Zheng ZQ, Liu D, Mei HY et al. Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J 2013; 41: 1116–1125.

    Article  CAS  Google Scholar 

  27. Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P et al. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 2009; 15: 1289–1297.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81300041, 81100038), the Natural Science Foundation of the Anhui Higher Education Institutions of China (KJ2012Z184), fund for the academic backbone of the excellent young and middle-aged people of Anhui Medical University (2013) and fund for reserve talents of the First Affiliated Hospital of Anhui Medical University (2014).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G-y Sun.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, R., Zhou, Sj., Zeng, Dx. et al. Plasmid-based short hairpin RNA against connective tissue growth factor attenuated monocrotaline-induced pulmonary vascular remodeling in rats. Gene Ther 21, 931–937 (2014). https://doi.org/10.1038/gt.2014.62

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2014.62

This article is cited by

Search

Quick links